158 related articles for article (PubMed ID: 20578261)
1. Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.
Matsuda A; Kuno A; Kawamoto T; Matsuzaki H; Irimura T; Ikehara Y; Zen Y; Nakanuma Y; Yamamoto M; Ohkohchi N; Shoda J; Hirabayashi J; Narimatsu H
Hepatology; 2010 Jul; 52(1):174-82. PubMed ID: 20578261
[TBL] [Abstract][Full Text] [Related]
2. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma.
Matsuda A; Kuno A; Matsuzaki H; Kawamoto T; Shikanai T; Nakanuma Y; Yamamoto M; Ohkohchi N; Ikehara Y; Shoda J; Hirabayashi J; Narimatsu H
J Proteomics; 2013 Jun; 85():1-11. PubMed ID: 23612463
[TBL] [Abstract][Full Text] [Related]
3. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
Tang Z; Yang Y; Wang X; Meng W; Li X
BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
[TBL] [Abstract][Full Text] [Related]
5. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.
Yamaguchi T; Yokoyama Y; Ebata T; Matsuda A; Kuno A; Ikehara Y; Shoda J; Narimatsu H; Nagino M
Ann Surg Oncol; 2016 Feb; 23(2):671-7. PubMed ID: 26416714
[TBL] [Abstract][Full Text] [Related]
6. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
[TBL] [Abstract][Full Text] [Related]
7. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma.
Bamrungphon W; Prempracha N; Bunchu N; Rangdaeng S; Sandhu T; Srisukho S; Boonla C; Wongkham S
Cancer Lett; 2007 Mar; 247(2):301-8. PubMed ID: 16793202
[TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
9. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
[TBL] [Abstract][Full Text] [Related]
10. The value of biliary fibronectin for diagnosis of cholangiocarcinoma.
Chen CY; Lin XZ; Tsao HC; Shiesh SC
Hepatogastroenterology; 2003; 50(52):924-7. PubMed ID: 12845951
[TBL] [Abstract][Full Text] [Related]
11. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.
Albiin N; Smith IC; Arnelo U; Lindberg B; Bergquist A; Dolenko B; Bryksina N; Bezabeh T
Acta Radiol; 2008 Oct; 49(8):855-62. PubMed ID: 18608012
[TBL] [Abstract][Full Text] [Related]
12. Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma.
Tamaki N; Kuno A; Matsuda A; Tsujikawa H; Yamazaki K; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Korenaga M; Mizokami M; Kurosaki M; Sakamoto M; Narimatsu H; Izumi N
Sci Rep; 2017 Mar; 7(1):244. PubMed ID: 28325920
[TBL] [Abstract][Full Text] [Related]
13. Lectin Microarray-Based Sero-Biomarker Verification Targeting Aberrant O-Linked Glycosylation on Mucin 1.
Matsuda A; Kuno A; Nakagawa T; Ikehara Y; Irimura T; Yamamoto M; Nakanuma Y; Miyoshi E; Nakamori S; Nakanishi H; Viwatthanasittiphong C; Srivatanakul P; Miwa M; Shoda J; Narimatsu H
Anal Chem; 2015 Jul; 87(14):7274-81. PubMed ID: 26091356
[TBL] [Abstract][Full Text] [Related]
14. The expression of MUC mucin in cholangiocarcinoma.
Mall AS; Tyler MG; Ho SB; Krige JE; Kahn D; Spearman W; Myer L; Govender D
Pathol Res Pract; 2010 Dec; 206(12):805-9. PubMed ID: 20947262
[TBL] [Abstract][Full Text] [Related]
15. Heat shock proteins 27 and 70 are potential biliary markers for the detection of cholangiocarcinoma.
Sato Y; Harada K; Sasaki M; Yasaka T; Nakanuma Y
Am J Pathol; 2012 Jan; 180(1):123-30. PubMed ID: 22051775
[TBL] [Abstract][Full Text] [Related]
16. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
17. Application of a glycoproteomics-based biomarker development method: alteration in glycan structure on colony stimulating factor 1 receptor as a possible glycobiomarker candidate for evaluation of liver cirrhosis.
Ocho M; Togayachi A; Iio E; Kaji H; Kuno A; Sogabe M; Korenaga M; Gotoh M; Tanaka Y; Ikehara Y; Mizokami M; Narimatsu H
J Proteome Res; 2014 Mar; 13(3):1428-37. PubMed ID: 24422531
[TBL] [Abstract][Full Text] [Related]
18. N-glycan structures of Wisteria floribunda agglutinin-positive Mac2 binding protein in the serum of patients with liver fibrosis†.
Noro E; Matsuda A; Kyoutou T; Sato T; Tomioka A; Nagai M; Sogabe M; Tsuruno C; Takahama Y; Kuno A; Tanaka Y; Kaji H; Narimatsu H
Glycobiology; 2021 Nov; 31(10):1268-1278. PubMed ID: 34192302
[TBL] [Abstract][Full Text] [Related]
19. Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1.
Matsuda A; Higashi M; Nakagawa T; Yokoyama S; Kuno A; Yonezawa S; Narimatsu H
Lab Invest; 2017 Sep; 97(9):1103-1113. PubMed ID: 28581490
[TBL] [Abstract][Full Text] [Related]
20. Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.
Metzger J; Negm AA; Plentz RR; Weismüller TJ; Wedemeyer J; Karlsen TH; Dakna M; Mullen W; Mischak H; Manns MP; Lankisch TO
Gut; 2013 Jan; 62(1):122-30. PubMed ID: 22580416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
